ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993